NFKB1 and chronic obstructive pulmonary disease: Administration of L. rhamnosus for COPD treatment (7 days prior to the COPD induction; thrice a week for 8 weeks) attenuates the inflammatory response and downregulates the expression of transcription factors, such as NF-κB and STAT3 in cigarette smoking-induced COPD mouse model [80].